Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106-116. https://doi.org/10.1016/S2214-109X(13)70145-1
Fleckenstein M, Mitchell P, Freund KB, Sadda S, Holz FG, Brittain C, Henry EC, Ferrara D (2018) The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125(3):369–390. https://doi.org/10.1016/j.ophtha.2017.08.038
Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N, Evans J, Ramke J, Kuper H, Burton MJ, Ehrlich JR, Swenor BK (2021) A global assessment of eye health and quality of life: a systematic review of systematic reviews. JAMA Ophthalmol 139(5):526–541. https://doi.org/10.1001/jamaophthalmol.2021.0146
Khachatryan N, Pistilli M, Maguire MG, Chang AY, Samuels MR, Mulvihill K, Salowe RJ, O’Brien JM (2021) A Review of studies of the association of vision-related quality of life with measures of visual function and structure in patients with glaucoma in the United States. Ophthalmic Epidemiol 28(3):265–276. https://doi.org/10.1080/09286586.2020.1863992
Article PubMed PubMed Central Google Scholar
Kimel M, Leidy NK, Tschosik E, Dolan C, Souied EH, Varma R, Bressler NM (2016) Functional reading independence (FRI) index: a new patient-reported outcome measure for patients with geographic atrophy. Invest Ophthalmol Vis Sci 57(14):6298–6304. https://doi.org/10.1167/iovs.16-20361
Heier JS, Pieramici D, Chakravarthy U, Patel SS, Gupta S, Lotery A, Lad EM, Silverman D, Henry EC, Anderesi M, Tschosik EA, Gray S, Ferrara D, Guymer R (2020) Visual Function decline resulting from geographic atrophy: results from the chroma and spectri phase 3 trials. Ophthalmol Retina 4(7):673–688. https://doi.org/10.1016/j.oret.2020.01.019
Sadda SR, Chakravarthy U, Birch DG, Staurenghi G, Henry EC, Brittain C (2016) Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration. Retina (Philadelphia, Pa) 36(10):1806–1822. https://doi.org/10.1097/iae.0000000000001283
Patel PJ, Ziemssen F, Ng E, Muthutantri A, Silverman D, Tschosik EA, Cantrell RA (2020) Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol (Auckland, NZ) 14:15–28. https://doi.org/10.2147/opth.S226425
Sivaprasad S, Tschosik EA, Guymer RH, Kapre A, Suner IJ, Joussen AM, Lanzetta P, Ferrara D (2019) Living with geographic atrophy: an ethnographic study. Ophthalmol Ther 8(1):115–124. https://doi.org/10.1007/s40123-019-0160-3
Article PubMed PubMed Central Google Scholar
Künzel SH, Möller PT, Lindner M, Goerdt L, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau M (2020) Determinants of quality of life in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 61(5):63. https://doi.org/10.1167/iovs.61.5.63
Article PubMed PubMed Central Google Scholar
Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, Dolan C, Silverman D (2018) Reliability and construct validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study. Am J Ophthalmol 190:1–8. https://doi.org/10.1016/j.ajo.2018.03.006
Kaiser E (2022) Tissue preservation should be considered as endpoint for geographic atrophy therapies. Modern Retina. https://www.modernretina.com/view/tissue-preservation-should-be-considered-as-endpoint-for-geographic-atrophy-therapies. Accessed June 12 2022
Shen LL, Sun M, Ahluwalia A, Young BK, Park MM, Toth CA, Lad EM, Del Priore LV (2021) Relationship of topographic distribution of geographic atrophy to visual acuity in nonexudative age-related macular degeneration. Ophthalmol Retina 5(8):761–774. https://doi.org/10.1016/j.oret.2020.11.003
Iveric Bio Announces Presentation of post-hoc analysis from GATHER1 clinical trial of Zimura® in Patients with Geographic Atrophy. (2022) Businesswire. https://www.businesswire.com/news/home/20220503006235/en/. Accessed June 12 2022
Age-Related Eye Disease Study Research G (1999) The age-related eye disease study (AREDS): design implications. AREDS report no 1. Control Clin Trials 20(6):573–600. https://doi.org/10.1016/s0197-2456(99)00031-8
Clemons TE, Chew EY, Bressler SB, McBee W, Age-Related Eye Disease Study Research G (2003) National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol 121(2):211–217. https://doi.org/10.1001/archopht.121.2.211
Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators Arch Ophthalmol 116(11):1496–1504. https://doi.org/10.1001/archopht.116.11.1496
Article CAS PubMed Google Scholar
Age-Related Eye Disease Study Research G (2001) The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 132(5):668–681. https://doi.org/10.1016/s0002-9394(01)01218-1
Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW (2017) Image J2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18(1):529. https://doi.org/10.1186/s12859-017-1934-z
Article PubMed PubMed Central Google Scholar
Shen LL, Sun M, Ahluwalia A, Young BK, Park MM, Del Priore LV (2021) Geographic atrophy growth is strongly related to lesion perimeter: unifying effects of lesion area, number, and circularity on growth. Ophthalmology Retina 5(9):868–878. https://doi.org/10.1016/j.oret.2020.12.002
Shen LL, Sun M, Ahluwalia A, Park MM, Young BK, Lad EM, Toth C, Del Priore LV (2022) Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degeneration. Br J Ophthalmol 106(5):689–695. https://doi.org/10.1136/bjophthalmol-2020-317636
Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, Bagoutdinov R, Hao L, Kiang A, Paschall J, Phan L, Popova N, Pretel S, Ziyabari L, Lee M, Shao Y, Wang ZY, Sirotkin K, Ward M, Kholodov M, Zbicz K, Beck J, Kimelman M, Shevelev S, Preuss D, Yaschenko E, Graeff A, Ostell J, Sherry ST (2007) The NCBI dbGaP database of genotypes and phenotypes. Nat Genet 39(10):1181–1186. https://doi.org/10.1038/ng1007-1181
Article CAS PubMed PubMed Central Google Scholar
Sivaprasad S, Chandra S, Kwon J, Khalid N, Chong V (2022) Perspectives from clinical trials: is geographic atrophy one disease? Eye (Lond). https://doi.org/10.1038/s41433-022-02115-1
Article PubMed PubMed Central Google Scholar
Cheng QE, Gao J, Kim BJ, Ying GS (2018) Design Characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrialsgov. Ophthalmol Retina 2(6):518–525. https://doi.org/10.1016/j.oret.2017.08.018
Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J, Tong B, Ehrlich JS, Bressler NM, Chroma Spectri Study I (2018) Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol 136(6):666–677. https://doi.org/10.1001/jamaophthalmol.2018.1544
Article PubMed PubMed Central Google Scholar
A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham injections in patients with geographic atrophy (GA) Secondary to age-related macular degeneration. (2021) NIH U.S. National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT03525613. Accessed June 5 2022
Kuester-Gruber S, Kabisch P, Cordey A, Karnath HO, Trauzettel-Klosinski S (2021) Training of vertical versus horizontal reading in patients with hemianopia - a randomized and controlled study. Graefes Arch Clin Exp Ophthalmol 259(3):745–757. https://doi.org/10.1007/s00417-020-04952-w
Article CAS PubMed Google Scholar
Huisingh C, McGwin G Jr, Wood J, Owsley C (2014) The driving visual field and a history of motor vehicle collision involvement in older drivers: a population-based examination. Invest Ophthalmol Vis Sci 56(1):132–138. https://doi.org/10.1167/iovs.14-15194
Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, Fine JT, Bressler NM (2011) Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci 52(6):3354–3359. https://doi.org/10.1167/iovs.10-5645
Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA, Submacular Surgery Trials Research G (2004) Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am J Ophthalmol 138 (1):91–108. https://doi.org/10.1016/j.ajo.2004.02.011
Ahluwalia A, Shen LL, Del Priore LV (2021) Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life. Graefes Arch Clin Exp Ophthalmol 259(2):307–316. https://doi.org/10.1007/s00417-020-04892-5
Sunness JS, Rubin GS, Broman A, Applegate CA, Bressler NM, Hawkins BS (2008) Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Ophthalmology 115(9):1480–1488, 1488 e1481–1482. https://doi.org/10.1016/j.ophtha.2008.03.009
Shen LL, Sun M, Ahluwalia A, Park MM, Young BK, Del Priore LV (2021) Local progression kinetics of geographic atrophy depends upon the border location. Invest Ophthalmol Vis Sci 62(13):28. https://doi.org/10.1167/iovs.62.13.28
Article PubMed PubMed Central Google Scholar
Shen LL, Xie Y, Sun M, Ahluwalia A, Park MM, Young BK, Del Priore LV (2021) Associations of systemic health and medication use with the enlargement rate of geographic atrophy in age-related macular degeneration. Br J Ophthalmol. https://doi.org/10.1136/bjophthalmol-2021-319426
留言 (0)